Institutional members access full text with Ovid®

Share this article on:

Evaluation of Vashe Wound Therapy in the Clinical Management of Patients with Chronic Wounds

Niezgoda, Jeffrey A MD, FACHM, FAPWCA, FACEP; Sordi, Peter J. MD, FACS; Hermans, Michel H.E. MD

Advances in Skin & Wound Care: August 2010 - Volume 23 - Issue 8 - p 352-357
doi: 10.1097/01.ASW.0000383198.35815.a2
Features: Original Investigations

OBJECTIVE: To analyze if Vashe Wound Therapy (PuriCore, Malvern, Pennsylvania) is a valuable contribution to standard protocols of wound care.

DESIGN: Open, noncomparative study.

SETTING: Outpatient clinic.

PATIENTS: Thirty-one patients, primarily with venous or mixed venous/arterial leg ulcers.

INTERVENTIONS: Vashe Wound Therapy (hypochlorous acid, produced on site and on demand) was used as an adjunct to a standard wound care protocol.

MAIN OUTCOME MEASURES: Wound healing, reduction of pain, and odor.

MAIN RESULTS: At the end of the study, 86% of all lesions healed, and the average size of reduction in nonhealed wounds was 47%. Odor was present at the beginning of enrollment in 21 patients and was rated 4.58 on the visual analog scale. In all patients, the odor score at end of treatment was zero. Seventy-seven percent of all patients reported a positive pain score at the beginning of participation in the evaluation (average pain score, 4.7). At the end of the study, no patient experienced pain.

CONCLUSION: Vashe Wound Therapy is a valuable contribution to standard protocols of wound care.

Jeffrey A. Niezgoda, MD, FACHM, FAPWCA, FACEP, is Medical Director, The Center for Comprehensive Wound Care and Hyperbaric Oxygen Therapy, Aurora St Luke's Medical Center, Milwaukee, Wisconsin. Peter J. Sordi, MD, FACS, is an Attending Physician, Department of Surgery, Glen Cove Hospital, Glen Cove, New York. Michel H.E. Hermans, MD, is Independent Consultant, Medical/Clinical Affairs, 3S Consulting Group, Inc, New York, New York.

© 2010 Lippincott Williams & Wilkins, Inc.